Cathepsin S Protein

Cathepsin S Protein

Introduction

Cathepsin S Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@kinney2018]

| Attribute | Value | [@xu2019]
|-----------|-------| [@liao2021]
| Protein Name | Cathepsin S |
| Gene Symbol | CTSS |
| UniProt ID | P25774 |
| PDB Structures | 1MS6, 1NQR, 1GLO, 2JPG |
| Molecular Weight | 37.5 kDa (proenzyme), 24.5 kDa (mature) |
| Subcellular Localization | Lysosomes, secreted |
| Protein Family | Papain family cysteine proteases |

</div>}

Overview

Cathepsin S Protein

Introduction

Cathepsin S Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@kinney2018]

| Attribute | Value | [@xu2019]
|-----------|-------| [@liao2021]
| Protein Name | Cathepsin S |
| Gene Symbol | CTSS |
| UniProt ID | P25774 |
| PDB Structures | 1MS6, 1NQR, 1GLO, 2JPG |
| Molecular Weight | 37.5 kDa (proenzyme), 24.5 kDa (mature) |
| Subcellular Localization | Lysosomes, secreted |
| Protein Family | Papain family cysteine proteases |

</div>}

Overview

Cathepsin S is a potent lysosomal cysteine protease with unique features that distinguish it from other cathepsins: it retains proteolytic activity at neutral pH and can be secreted extracellularly.^[1] These properties make cathepsin S important in antigen presentation, extracellular matrix degradation, and various disease processes including Alzheimer's disease, multiple sclerosis, and cancer.

Structure

Domain Organization

Cathepsin S is synthesized as a preproenzyme:

Crystal Structure

• Active site: Cys139, His299, Asn319 (catalytic triad)
• Specificity pocket: S2 pocket prefers hydrophobic residues
• Occluding loop: Unique among cathepsins, affects substrate access

PDB Structures

| PDB ID | Description | Resolution |
|--------|-------------|------------|
| 1MS6 | Native structure | 2.0 Å |
| 1NQR | With inhibitor | 1.8 Å |
| 1GLO | Complex with cystatin | 2.3 Å |
| 2JPG | Active site mutant | 2.1 Å |

Normal Function

Proteolytic Activity

Cathepsin S cleaves various substrates:^[2]

• Invariant chain (CD74): Enables MHC class II antigen presentation
• Elastin: Elastic fiber degradation
• Collagen types I-IV: Extracellular matrix remodeling
• Fibronectin: Matrix component cleavage
• Cytokines: Processing and activation

Key Biological Processes

• Degrades invariant chain in late endosomes/lysosomes
• Generates antigenic peptides
• Essential for CD4+ T cell development

• Active at neutral pH (unique among cathepsins)
• Degrades ECM in inflammation
• Processes bioactive molecules

• Activates proteases (cathepsin G, MMPs)
• Generates bioactive fragments

Role in Disease

Alzheimer's Disease

Cathepsin S has complex roles in AD:^[3]

• Aβ degradation: Can degrade [amyloid-beta](/proteins/amyloid-beta) (protective)
• Neuroinflammation: Promotes microglial activation
• [BBB](/entities/blood-brain-barrier) breakdown: May increase vascular permeability
• Neuronal injury: Elevated in AD brains

Multiple Sclerosis

• Demyelination: Active in MS lesions
• Myelin degradation: Cathepsin S degrades myelin basic protein
• Therapeutic target: Inhibitors reduce disease in animal models

Autoimmune Diseases

• Rheumatoid arthritis: Cartilage degradation
• Inflammatory bowel disease: Tissue damage
• Lupus: Immune dysregulation

Cancer

• Tumor invasion: ECM degradation
• Metastasis: Migration through basement membranes
• Angiogenesis: Processes VEGF

Therapeutic Targeting

Cathepsin S is a drug target:^[4]

| Strategy | Compound | Stage |
|----------|----------|-------|
| Inhibitors | MIV-247, LHVS | Preclinical |
| Antibodies | Rymovutide | Clinical trials |
| Selectivity | Over cathepsins B, L | Challenge |

Key Publications

Background

The study of Cathepsin S Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[@seven2022]: Seven E, et al. "Cathepsin S as a target in neurodegenerative diseases." Neuropeptides. 2022;95:102312. PMID: 36183892(https://pubmed.ncbi.nlm.nih.gov/36183892/)
[@kinney2018]: Kinney JW, et al. "Cathepsin B: A potential therapeutic target in neurodegenerative disease." Biol Chem. 2018;399(9):1003-1018. PMID: 29933437(https://pubmed.ncbi.nlm.nih.gov/29933437/)
[@xu2019]: Xu J, et al. "Cathepsin S activity in Alzheimer's disease." J Neurochem. 2019;151(4):491-504. PMID: 31180164(https://pubmed.ncbi.nlm.nih.gov/31180164/)
[@liao2021]: Liao Y, et al. "Targeting cathepsin S for Alzheimer's disease therapy." Front Aging Neurosci. 2021;13:756890. PMID: 34658856(https://pubmed.ncbi.nlm.nih.gov/34658856/)

See Also

• [Cathepsins](/genes/cat)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Multiple Sclerosis](/diseases/multiple-sclerosis)
• Lysosomal Proteases
• MHC Class II Antigen Presentation

External Links

• [UniProt: P25774](https://www.uniprot.org/uniprotkb/P25774)
• [PDB: 1MS6](https://www.rcsb.org/structure/1MS6)
• [AlphaFold: P25774](https://alphafold.ebi.ac.uk/entry/P25774)
• [CATH: 1MS6](http://www.cathdb.info/version/latest/domain/1ms6)

Pathway Diagram

The following diagram shows the key molecular relationships involving Cathepsin S Protein discovered through SciDEX knowledge graph analysis: